Free Membership
Newsletter
Help
Subscribe
Sign In
Search
April 1, 2023
All times are Vienna time
Search
Subscribe
Sign In
Countries:
Africa »
Algeria Angola Benin Botswana Burundi Côte d'Ivoire Ethiopia Ghana Guinea Kenya Lesotho Liberia Libya Mali Mauritius Morocco Mozambique Namibia Niger Nigeria Rwanda South Africa Sudan Tanzania The Congo Togo Tunisia Uganda Zambia Zimbabwe
Asia-Pacific »
Afghanistan Australia Bangladesh Cambodia China Hong Kong SAR India Indonesia Japan Laos Malaysia Mongolia Myanmar Nepal New Zealand North Korea (DPRK) Pakistan Philippines Singapore South Korea Sri Lanka Taiwan Thailand Vietnam
Central- & Eastern Europe »
Albania Bosnia & Herzegovina Bulgaria Croatia Czech Rep. Estonia Georgia Hungary Kosovo Latvia Lithuania North Macedonia Montenegro Poland Romania Serbia Slovakia Slovenia Ukraine Western Balkans
Middle East »
Egypt Iran Iraq Israel Jordan Kuwait Lebanon Oman Palestinian Territories Qatar Saudi Arabia Syria Turkey United Arab Emirates Yemen
Russia & CIS »
Russia Armenia Azerbaijan Belarus Kazakhstan Kyrgyzstan Moldova Turkmenistan Uzbekistan
The Americas »
Argentina Bolivia Brazil Canada Central America Chile Colombia Cuba Ecuador Mexico Panama Paraguay Peru The Caribbean Uruguay Venezuela
United States
Western Europe »
Belgium Cyprus Denmark Finland France Germany Greece Iceland Ireland Italy Liechtenstein Luxembourg Malta Monaco Norway Portugal Scotland Spain Sweden Switzerland The Netherlands United Kingdom Vatican City
Business:
Economy
Economic Policies
Investing in Austria
Securities
Earnings
Foreign Trade
Deals
Legal Issues
More Business & Economics+
Politics:
Domestic
Brussels
International
Diplomacy
Companies:
Professional Services »
Banks Financial Services Real Estate Insurance Other Services
Energy »
Oil & Gas Utilities Renewables Mining
Industrials »
Construction Automotive Industrial Goods Basic Resources Chemicals Other Industrials
Transport »
Airlines & Airports Shipping Rail Road
Retail & Consumer
Health Care
Technology
Telecoms
Media
Tourism
Other
Organizations:
Diplomatic Missions
International Organizations
Other
People:
Executives
Politicians
Diplomats
Entrepreneurs
Other
Lifestyle & Travel:
Culture
Travel
Personal Real Estate
Health
Food & Drink
Luxury Goods
More+
More+:
Events
Photo Galleries
Videos
Classifieds
Work & Careers
More+
Home
Countries
Business
Politics
Diplomacy
Companies
Organizations
People
Lifestyle & Travel
More+
Africa
Algeria
Angola
Benin
Botswana
Burundi
Côte d'Ivoire
Ethiopia
Ghana
Guinea
Kenya
Lesotho
Liberia
Libya
Mali
Mauritius
Morocco
Mozambique
Namibia
Niger
Nigeria
Rwanda
South Africa
Sudan
Tanzania
The Congo
Togo
Tunisia
Uganda
Zambia
Zimbabwe
Asia-Pacific
Afghanistan
Australia
Bangladesh
Cambodia
China
Hong Kong SAR
India
Indonesia
Japan
Laos
Malaysia
Mongolia
Myanmar
Nepal
New Zealand
North Korea (DPRK)
Pakistan
Philippines
Singapore
South Korea
Sri Lanka
Taiwan
Thailand
Vietnam
Central- & Eastern Europe
Albania
Bosnia & Herzegovina
Bulgaria
Croatia
Czech Rep.
Estonia
Georgia
Hungary
Kosovo
Latvia
Lithuania
North Macedonia
Montenegro
Poland
Romania
Serbia
Slovakia
Slovenia
Ukraine
Western Balkans
Middle East
Egypt
Iran
Iraq
Israel
Jordan
Kuwait
Lebanon
Oman
Palestinian Territories
Qatar
Saudi Arabia
Syria
Turkey
United Arab Emirates
Yemen
Russia & CIS
Russia
Armenia
Azerbaijan
Belarus
Kazakhstan
Kyrgyzstan
Moldova
Turkmenistan
Uzbekistan
The Americas
Argentina
Bolivia
Brazil
Canada
Central America
Chile
Colombia
Cuba
Ecuador
Mexico
Panama
Paraguay
Peru
The Caribbean
Uruguay
Venezuela
United States
Western Europe
Belgium
Cyprus
Denmark
Finland
France
Germany
Greece
Iceland
Ireland
Italy
Liechtenstein
Luxembourg
Malta
Monaco
Norway
Portugal
Scotland
Spain
Sweden
Switzerland
The Netherlands
United Kingdom
Vatican City
Economy
Economic Policies
Investing in Austria
Securities
Earnings
Foreign Trade
Deals
Legal Issues
More Business & Economics+
Domestic
Brussels
International
Professional Services
Banks
Financial Services
Real Estate
Insurance
Other Services
Energy
Oil & Gas
Utilities
Renewables
Mining
Industrials
Construction
Automotive
Industrial Goods
Basic Resources
Chemicals
Other Industrials
Transport
Airlines & Airports
Shipping
Rail
Road
Retail & Consumer
Health Care
Technology
Telecoms
Media
Tourism
Other
Diplomatic Missions
International Organizations
Other
Executives
Politicians
Diplomats
Entrepreneurs
Other
Culture
Travel
Personal Real Estate
Health
Food & Drink
Luxury Goods
More+
Events
Photo Galleries
Videos
Classifieds
Work & Careers
More+
Latest News
Ukrainian War
Covid in Austria
USA in Vienna
UK in Vienna
Russia in Vienna
China in Vienna
Iran in Vienna
UN
OSCE
IAEA
OPEC
Sponsored Content
Tweet
Share

EMA Approves Second Covid-19 Vaccine: Austria Receives 890,000 Doses

Lifestyle & Travel › Health ♦ Published: January 7, 2021; 16:20 ♦ (Vindobona)
Sponsored Content

The European Medical Agency (EMA) and the European Commission have approved the second Covid-19 vaccine for EU member states. The vaccine from the producer Moderna will provide Austria with another 890,000 doses in the first half of 2021. Austria's Health Minister expects approval for the vaccine from AstraZeneca by February.

The Covid-19 vaccine from the biotechnology company Moderna with headquarters in Cambridge, USA, has been approved by the EMA. / Picture: © Wikimedia Commons / Fletcher / CC BY 4.0 (https://creativecommons.org/licenses/by/4.0)

The European Commission approved Moderna's Covid-19 vaccine.

The green light followed a scientific recommendation from the European Medicines Agency (EMA) based on a thorough evaluation of the vaccine's safety, efficacy and quality.

EU member states also gave their approval.

Sponsored Content

EU Commission President von der Leyen said:

"We are providing more Covid-19 vaccines for Europeans. With the Moderna vaccine, the second one now authorized in the EU, we will have a further 160 million doses. And more vaccines will come. Europe has secured up to two billion doses of potential Covid-19 vaccines. We'll have more than enough safe and effective vaccines for protecting all Europeans."

The first to be licensed in the EU, BioNTech/Pfizer's vaccine was approved December 21 and is already in use.

The European Commission, on behalf of all member states, has secured 200 million doses of BioNTech/Pfizer's vaccine and agreed an option for an additional 100 million doses, which is now being activated.

As part of the EU Vaccine Strategy initiated in June 2020, the Commission is entering into off-take guarantees with vaccine manufacturers on behalf of the member states, thereby also supporting the companies in developing the vaccines and expanding production capacity.

To date, agreements have been reached with AstraZeneca, BioNTech/Pfizer, Sanofi-GSK, Johnson & Johnson, CureVac and Moderna.

In addition, exploratory discussions were concluded with Novavax.

In building the diversified vaccine portfolio - currently comprising up to two billion doses - the EU is focusing on different manufacturers and different technologies in order to spread the risk.

Once vaccines are proven safe and effective, all member states will be able to purchase them at the same time and on the same terms.

"The recommendation by the EMA for approval of the marketing authorization of a second vaccine is good news for the EU and for Austria - our predictions have been fulfilled once again. I now expect AstraZeneca's vaccine to receive marketing authorization in February. This means that our vaccination strategy can be implemented step by step as planned," says a delighted Austrian Health Minister Rudolf Anschober.

Sponsored Content

Austria expects Moderna to deliver 200,000 vaccine doses in the first quarter and 690,000 in the second quarter, for a total of 890,000 doses in the first half of the year.

The vaccine from Moderna also requires two vaccinations and cold storage - at minus 20 degrees Celsius.

Thus, after these two approvals, Austria will receive 927,000 doses of the BioNTech/Pfizer vaccine and 200,000 doses of the Moderna vaccine in the first quarter.

Copyright © Vindobona. You may share using our article tools. Please don't cut articles from Vindobona and redistribute by email or post to the web.
Sponsored Content
Fast News Search
Related News
Covid-19 Vaccine: Good Tolerability So Far in Austria (January 4, 2021)
Covid-19 Vaccine: Austria Starts on December 27 (December 23, 2020)
EMA Approves Covid-19 Vaccine (December 21, 2020)
Read More
Vaccines, Rudolf Anschober, Moderna, EU European Union, EC European Commission, EMA European Medicines Agency, COVID-19, Coronavirus
Featured
See latest Vindobona Newsletter
Sign up now for full site access and to read a limited amount of free premium articles per month:
Sign Up
×
Sponsored Content
Sponsored Content
©1995-2023 Vindobona
Contact
Help
Imprint
Press
Careers
Partners
Terms & Conditions
Site Security
Privacy
Sitemap
Advertise
About Us